HEPATITIS B IMMUNOGLOBULIN (HUMAN) — all Canadian products
8 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is HEPATITIS B IMMUNOGLOBULIN (HUMAN), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02290979 | HEPAGAM B | KI BIOPHARMA LLC | Solution | Intramuscular; Intravenous | HEPATITIS B IMMUNOGLOBULIN (HUMAN) 312 UNIT | Marketed | |
| 02520001 | HYPERHEP B | GRIFOLS THERAPEUTICS LLC | Solution | Intramuscular | HEPATITIS B IMMUNOGLOBULIN (HUMAN) 220 UNIT | Marketed | |
| 02520133 | HYPERHEP B | GRIFOLS THERAPEUTICS LLC | Solution | Intramuscular | HEPATITIS B IMMUNOGLOBULIN (HUMAN) 220 UNIT | Approved | |
| 02520125 | HYPERHEP B | GRIFOLS THERAPEUTICS LLC | Solution | Intramuscular | HEPATITIS B IMMUNOGLOBULIN (HUMAN) 110 UNIT | Marketed | |
| 00780251 | H-BIG | ABBOTT LABORATORIES, LIMITED | Liquid | Intramuscular | HEPATITIS B IMMUNOGLOBULIN (HUMAN) 1.5 UNIT | Cancelled Post Market | |
| 02379473 | HYPERHEP B S/D | GRIFOLS THERAPEUTICS LLC | Solution | Intramuscular | HEPATITIS B IMMUNOGLOBULIN (HUMAN) 220 UNIT | Cancelled Pre Market | |
| 02379465 | HYPERHEP B S/D | GRIFOLS THERAPEUTICS LLC | Solution | Intramuscular | HEPATITIS B IMMUNOGLOBULIN (HUMAN) 220 UNIT | Cancelled Post Market | |
| 02230738 | HYPERHEP B S/D | GRIFOLS THERAPEUTICS LLC | Solution | Intramuscular | HEPATITIS B IMMUNOGLOBULIN (HUMAN) 220 UNIT | Cancelled Post Market |
Browse other molecules: